DH 4243

Drug Profile

DH 4243

Alternative Names: DH-4243; Tranexamic acid - Daiichi

Latest Information Update: 12 May 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Daiichi Sankyo Company
  • Class Antifibrinolytics; Antihaemorrhagics; Cyclohexanecarboxylic acids; Skin disorder therapies; Small molecules
  • Mechanism of Action Plasmin inhibitors; Plasminogen activator inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Melanosis; Skin disorders

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 12 May 2008 Discontinued - Clinical-Phase-Unknown for Melanosis in Japan (PO)
  • 12 May 2008 Discontinued - Clinical-Phase-Unknown for Skin disorders in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top